This content is presented in collaboration with Drug Target Review
Identify and isolate rare antigen-specific B cells from large heterogeneous populations in just two days.
In this application note, we describe a robust and rapid single B cell screening method to identify antibodies of desired antigenic specificity without the laborious need for traditional hybridoma screening.
Cyto-Mine® enables the deep interrogation of whole B cell repertoires or hybridoma populations while preserving cell viability.
Download the application note to find out how Cyto-Mine® can screen, select and dispense antibody-secreting cells with antigen specificity by encapsulating up to 40 million cells in one run, assaying for the target antigen, selecting antigen-specific antibody-secreting cells, and dispensing as a pooled population or as single cells into 96- or 384-well microtiter plates.